Stemtech Corp (STEK)

↓ Download CSV

CIK 0001511820 · OTC · Wholesale-Drugs, Proprietaries & Druggists' Sundries

  • Sector Wholesale Trade
  • Fiscal year ends Dec 31

In fiscal 2025, Stemtech Corp reported revenue of $2.88M, down 43.1% from the prior year. The company ran a net loss, with a net margin of -140.7% and a gross margin of 80.3%. It held $3.15M in total assets against $10.59M in total liabilities.

Key ratios (FY2025)

80.3%
Gross margin
-94.2%
Operating margin
-140.7%
Net margin
-43.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$2.88M$5.05M$4.92M$4.56M$4.32M$4.38M
Cost of Revenue$566.9K$1.33M$1.00M$1.16M$1.02M
Gross Profit$2.31M$3.73M$3.92M$3.40M$3.30M$3.67M
Operating Income-$2.71M-$2.39M-$4.22M-$5.02M-$3.21M-$1.43M-$20.1K-$24.8K-$36.5K-$23.5K
Net Income-$4.05M-$3.77M-$5.43M-$8.54M-$7.08M-$916.7K-$33.8K-$37.3K-$46.3K-$28.4K
EPS (Diluted)$-0.02$-0.03$-0.07$-0.19$-0.20$-0.10
Total Assets$3.15M$3.78M$3.68M$4.27M$5.72M$5.01M$2.9K$14.8K$17.1K$9.6K
Total Liabilities$10.59M$8.74M$6.46M$7.44M$9.73M$3.74M$194.3K$172.4K$137.4K
Shareholders' Equity-$6.96M-$4.48M-$2.04M-$2.43M-$3.36M-$225.8K-$191.4K-$157.6K-$120.3K-$94.0K
Cash & Equivalents$132.5K$828.2K$133.1K$714$8.2K$8.6K$3.7K
Operating Cash Flow-$483.6K-$601.2K-$2.04M-$1.22M-$1.91M-$266.7K-$11.4K-$25.4K-$24.8K-$37.0K
Capital Expenditures$0$0$0$11.6K
Shares Outstanding425.98M135.76M104.99M53.44M44.69M34.25M